Normal pressure hydrocephalus (NPH) …

Neurobehavioral & Cognitive Disorders

Updated 04.28.2024
Released 04.22.1994
Expires For CME 04.28.2027

Normal pressure hydrocephalus

Authors: Peter Hedera MD PhD, Robert P Friedland MD

See Contributor Disclosures

Editor: Howard S Kirshner MD

Normal pressure hydrocephalus

In This Article

Quick Link

Introduction

Overview

Normal pressure hydrocephalus is characterized by enlarged ventricles and tightened parasagittal cortical sulci with a characteristic clinical presentation of gait disorder, cognitive decline, and urinary incontinence. Shunt surgery is the only established effective treatment. In this updated article, the authors provide an overview of clinical features suggesting normal pressure hydrocephalus as well as diagnostic approaches to establishing this diagnosis and selecting patients who have the highest likelihood of improvement after shunting. Although normal pressure hydrocephalus is relatively rare, prompt recognition and surgical treatment of this condition can significantly reverse clinical features and improve the long-term outcome of these patients.

Key points

	• Normal pressure hydrocephalus is characterized by gait disorder, cognitive decline, and urinary incontinence.
	• Prompt recognition and treatment may reverse clinical symptoms of normal pressure hydrocephalus.
	• Diagnosis of normal pressure hydrocephalus is based on a combination of clinical symptoms, neuroradiologic abnormalities, and transient improvement after CSF drainage.
	• Shunt surgery is the only established treatment of normal pressure hydrocephalus.

Historical note and terminology

The triad of progressive dementia, gait disturbances, and urinary incontinence was originally described as a distinct syndrome by Adams and colleagues (02; 42). Several other terms have been used to describe this condition, reflecting uncertainties about the pathogenesis of normal pressure hydrocephalus: "communicating," "low-pressure," "nonobstructive," "internal," "tension," "hydrostatic," "intermittent-tension," and "variotensive" hydrocephalus. The eponym "Hakim-Adams syndrome" is also occasionally used.

Clinical manifestations

Presentation and course

Gait impairment associated with urinary incontinence and cognitive decline is suggestive of normal pressure hydrocephalus. Gait and stance difficulties are usually an early sign, and they may appear before, shortly after, or simultaneously with intellectual changes. Urinary incontinence is typically a late symptom. Gait disturbance may be a unique presentation of normal pressure hydrocephalus, and incontinence is the most commonly missing symptom from the triad. Urinary urgency may sometimes precede the development of incontinence. Fecal incontinence is rare and appears in more advanced stages. The clinical manifestations of normal pressure hydrocephalus are insidious and, if untreated, this condition is inevitably progressive with gradual progression of dementia and advancement to an akinetic state.

Patients with normal pressure hydrocephalus walk slowly, are unsteady, and have a wide base. A review of 1716 articles describing the clinical features of normal pressure hydrocephalus identified "wide-based gait" as the most common gait dysfunction (15). Steps are short with reduced step height, a pattern of gait referred to as "magnetic gait" (34; 73).

Gait apraxia (1)

When attempting to walk, the patient appears to be glued to the floor. (Contributed by Dr. Joseph Jankovic.)
Arising impairment (2)

The patient can arise only when pulled up by an assistant. (Contributed by Dr. Joseph Jankovic.)

Postural instability is also common, with increased risk of falls. Turning is awkward and en block with multiple steps. Patients often complain about leg weakness, tiredness, and occasional numbness or burning sensations. These symptoms fluctuate from day to day. In advanced stages, standing, and later sitting, may become impossible. Neurologic examination may reveal a mild degree of spasticity with increased muscle stretch reflexes in the lower extremities, and Babinski signs also may be present. Upper extremities are initially spared, but changes in handwriting, poor coordination on fine motor tasks, and postural tremor have been reported in later stages.

The gait difficulties in normal pressure hydrocephalus must be distinguished from those caused by weakness. Lower extremity strength in normal pressure hydrocephalus is preserved. Motor abilities can be tested with patients sitting or lying down by asking them to imitate walking, riding a bicycle, or other motions. Typically, they can perform these tasks without obvious deficit, and these abilities are preserved until relatively late stages. This pattern of gait disturbance indicates gait "apraxia" rather than muscle weakness.

Normal pressure hydrocephalus may have additional manifestations beyond a classic triad. Motor impairment may also affect the upper limbs, and slowing of rapid alternating movements is seen commonly in patients with normal pressure hydrocephalus; a successful shunting of hydrocephalus also improves the dexterity in the upper extremities (89).

Cognitive decline varies widely in its severity. Dementia is characterized by prominent attention deficit, memory impairment, and executive (frontal lobe) dysfunction. Most patients are apathetic; bradyphrenia and depression must be considered. Aphasia, other than anomia, and apraxia are usually not prominent. However, cognitive symptoms in normal pressure hydrocephalus are not limited to features of so-called subcortical dementia (eg, abulia, bradyphrenia, distractibility, memory deficit). Focal cortical deficits (aphasia, apraxia, agnosia) may occur as well, blurring the distinction between dementia in normal pressure hydrocephalus and the primary degenerative dementias. Behavioral symptomatology can be marked in some patients. Akinetic mutism and alteration of consciousness are found in the later stages.

Clinical vignette

A 73-year-old man with an unremarkable past medical history presented after a 3-year history of progressive forgetfulness and poor balance as well as recent onset of urinary incontinence. Examination showed impaired memory and difficulties with calculations and visuospatial skills. Language was normal. The patient’s Mini-Mental State Examination score was 23/30. The rest of the neurologic examination was notable for diminished postural reflexes and abnormal gait with signs of gait apraxia. Laboratory tests did not reveal any treatable cause of dementia. X-ray computed tomography demonstrated enlarged ventricles and hypodensity of the white matter. Lumbar puncture was performed with normal opening pressure, and 30 cc of CSF were collected. CSF analysis was normal. The patient’s gait transiently improved with better stride and improved postural reflexes.

A diagnosis of normal pressure hydrocephalus was made based on the presence of the clinical triad and typical neuroimaging studies. The patient underwent ventriculoperitoneal shunting. X-ray computed tomography obtained after the operation was unchanged from his previous imaging.

Normal-pressure hydrocephalus after ventriculoperitoneal shunt placement (CT)

Typically, enlarged ventricles and severe periventricular hypodensities are present; also note small pneumocephalus on (A) after shunt placement. (Contributed by Dr. Peter Hedera.)

One month after shunt placement, the patient experienced significant improvement in gait and bladder control. His cognition also improved, and his repeat Mini-Mental State Examination score was 28/30. A follow-up CT demonstrated reduction of hypodensities in the periventricular white matter. The ventricular size was not significantly changed.

Biological basis

Etiology and pathogenesis

Biological basis. Hydrocephalus in normal pressure hydrocephalus is a consequence of the disequilibrium between production and absorption of CSF. It is thought that, in the majority of cases, ventricular enlargement results from an obstruction of the CSF flow around the brain convexities and insufficient absorption through the arachnoid granulations and arachnoid villi of the superior sagittal sinus. Subarachnoid hemorrhage, meningitis, head injuries, and elevated levels of CSF protein all cause scarring and fibrosis in the subarachnoid space (69). Deficiency of the arachnoid granulations and obstruction of the pacchionian villi due to meningioma of the superior sagittal sinus are other examples of this mechanism. This subtype of normal pressure hydrocephalus is often referred to as communicating hydrocephalus. Communication between the ventricles and subarachnoid space is unobstructed; however, the communication between the subarachnoid space and arachnoid granulations is not intact. Other lesions (intracranial tumors, cerebellar hematomas, nontumorous stenosis of the aqueduct of Sylvius, arachnoid cysts) can result in normal pressure hydrocephalus due to obstruction of CSF circulation within the ventricular system. This subtype of normal pressure hydrocephalus is sometimes called noncommunicating.

A relatively large proportion of patients with normal pressure hydrocephalus do not have an identifiable cause of hydrocephalus. The preponderance of evidence in these cases points to reduced absorption of CSF. Patients with normal pressure hydrocephalus (both idiopathic and secondary) have increased resistance to outflow (ROUT) of CSF (ROUT, mmHg/mL per minute), suggestive of an impediment of CSF absorption (66). This has been corroborated by pathological studies showing fibrotic changes of the leptomeninges and pacchionian villi (69). Genetic predisposition has been increasingly recognized as an important cause of normal pressure hydrocephalus, but the genetic landscape of normal pressure hydrocephalus remains unknown (108).

Normal opening pressure of CSF and abnormally high outflow resistance indicate that normal pressure is an endpoint of previously elevated intracranial pressure (66). Indeed, intracranial pressure is not always normal, and long-term monitoring has shown transient elevation of intracranial pressure. Thus, elevation of intracranial pressure causes enlargement of ventricles, and a new balance is reached with normal (ie, nonelevated) pressure but higher force, affecting a bigger ventricular surface according to Pascal's law of pressure in fluids (42). Reduced compliance of the brain, further enhanced by degenerative changes of the periventricular white matter, may also contribute to abnormal distensibility of the ventricles. Increased CSF pulse amplitude is another possible explanation for the development of hydrocephalus despite normal intracranial pressure (35).

The development of the clinical symptoms of normal pressure hydrocephalus is multifactorial. Motor fibers innervating the legs and sphincters project through the vicinity of the frontal horns of the lateral ventricles. The frontal horns of the lateral ventricles are often disproportionally expanded. Stretching of these fibers is thought to be responsible for gait and urinary symptoms. Volumetric changes after CSF removal are most pronounced in the periventricular region of the lateral ventricles and in the frontal and temporal lobes (104). Corticospinal tract fibers show signs of axonal degeneration, which can be clinically assessed by diffusion tensor imaging (46; 55). Tractography of white matter confirmed gait-related white matter structural abnormalities in motor and sensory pathways around the ventricle (111).

Early urinary involvement is characteristic of the loss of voluntary supraspinal control with bladder hyperactivity and detrusor instability, which is manifested as urinary urgency. Late frank incontinence also has a frontal component with indifference and lack of concern. Many symptoms of cognitive decline can also be accounted for by compression of the frontal white matter (deficits in attention, initiation, and other executive functions).

Compromised microcirculation due to increased intraparenchymal pressure is another putative factor in the pathogenesis of dementia and the apractic features of gait. Studies of regional cerebral blood flow in normal pressure hydrocephalus have shown regional reduction of blood flow in the periventricular white matter with gradual improvement toward the cortical regions. Induction of increased intracranial pressure further reduced cerebral blood flow in the subcortical regions (87).

Impaired vascular autoregulation with reduced cerebrovascular reactivity, suggesting a limited capacity to compensate for transitional increases of intracranial pressure, is also a feature of normal pressure hydrocephalus (25). Clinical changes do not tightly correlate with regional cerebral blood flow changes; the degree of clinical improvement has been disproportionally higher than changes of regional cerebral blood flow. This suggests that additional factors (such as demyelinization and decreased clearance of various macromolecules) may play roles in the pathogenesis of dementia in normal pressure hydrocephalus (103; 121).

Results of quantitative studies of the brain metabolism are more consistent. Jagust and colleagues found global reduction of glucose metabolism using PET; patients with normal pressure hydrocephalus had a different pattern compared to patients with Alzheimer disease (51). The decrease of glucose uptake in normal pressure hydrocephalus is lower than expected for the degree of dementia and suggests widespread cortical and subcortical dysfunction. The relationship between symptoms of normal pressure hydrocephalus and alterations of blood flow and cerebral metabolism is not firmly established. Clinical motor symptoms may be caused by blood flow abnormalities in the supplementary motor cortex, causing reversible suppression of frontal periventricular corticobasal ganglia-thalamocortical pathways. This area showed improved blood flow after a prolonged lumbar drainage, suggesting that motor function recovery in patients with normal pressure hydrocephalus after CSF removal is related to enhanced activity in medial parts of frontal motor areas that are important for motor planning (71).

Striatal dopaminergic dysfunction has been suggested in the motor phenotypic expression of normal pressure hydrocephalus (116). Reduced striatal dopamine reuptake transporter binding can be seen in more than half of these patients, and it correlated with the severity of parkinsonism but not with features of ventriculomegaly or white matter changes. Unlike in idiopathic Parkinson disease, dopaminergic deficit in normal pressure hydrocephalus is more symmetric and prominent in the caudate nucleus (98). Absence of levodopa responsiveness, shunt-responsive parkinsonism, and post-surgery improvement of striatal DAT density are findings that corroborate the notion of a reversible striatal dysfunction in a subset of patients with idiopathic normal pressure hydrocephalus.

Impaired corticospinal excitability, assessed by transcranial magnetic stimulation, can result in disinhibition of the motor cortex and, thus, plays a key role in mediating the effects of frontal lobe dysfunction on motor performance in patients with normal pressure hydrocephalus (28). These abnormalities likely reflect a disturbed connectivity of the frontal motor networks rather than a direct lesion of the primary motor cortex or corticospinal tract, and shunting can normalize transcranial magnetic stimulation responses.

Ischemia of deep white matter may not be a mandatory precondition for the development of normal pressure hydrocephalus because not every patient with normal pressure hydrocephalus has abnormal blood flow studies; however, secondary microcirculation changes may be caused by stretching of periventricular white matter due to ventriculomegaly. MR imaging studies with flow quantification measuring the total blood inflow, sagittal and straight sinus outflow, aqueduct stroke volume, and arteriovenous delay did not detect any abnormalities in the periventricular regions, and the main changes showed alterations in superficial venous compliance and a reduction in the blood flow returning via the sagittal sinus (11). The overall load of the white matter changes also negatively correlated with the gait improvement after shunting, further supporting the notion that white matter lesions contribute to the irreversibility of symptoms in normal pressure hydrocephalus but not to the pathophysiological mechanisms that lead to them (22). Diffusion microstructural MR imaging may be helpful to distinguish reversible and irreversible white matter changes in this condition (58).

Altered glymphatic system has also been implicated in the pathogenesis of normal pressure hydrocephalus (109). Diffusion Tensor Image-Analysis aLong the Perivascular Space (DTI-ALPS) showed abnormalities in patients with normal pressure hydrocephalus, and the group of nonresponders to shunting procedure had even lower ALPS-index than shunt responders (10; 39). Patients with normal pressure hydrocephalus have fewer enlarged perivascular spaces than cognitively intact individuals. This pattern may be caused by mechanical obstruction due to upward displacement of the brain leading to reduced glymphatic clearance (107).

Abnormalities of jugular venous system draining the blood from the brain can contribute to abnormal absorption of CSF. Incompetent jugular valves may allow the transmission of the high venous pressures to the subarachnoid space. This hypothesis is supported by the findings of retrograde jugular flow during Valsalva maneuver in 95% patients with normal pressure hydrocephalus, and this finding is rare in apparently normal controls (68). This test can be also used for the diagnosis of normal pressure hydrocephalus, even though its specificity and sensitivity have not been established in a larger cohort of patients.

Etiology. Approximately one half of all cases of normal pressure hydrocephalus were historically considered idiopathic without apparent cause. There is growing evidence that vascular risk factors are important in the pathogenesis of idiopathic normal pressure hydrocephalus. A population-based study identified hypertension, white matter disease, and diabetes mellitus as important risk factors for the development of communicating hydrocephalus (52). Genetic analysis using the Mendelian randomization approach also supports essential hypertension as a causal risk factor for idiopathic normal pressure hydrocephalus (30).

Subarachnoid hemorrhage, head trauma, infectious or carcinomatous meningitis, and elevated CSF protein levels (including elevation due to intraspinal tumors) are causes of secondary normal pressure hydrocephalus. Normal pressure hydrocephalus may also result from aqueductal stenosis, arachnoid cysts of the third and fourth ventricles, basilar artery ectasia, and intracranial and spinal tumors.

A familial form of normal pressure hydrocephalus with autosomal dominant inheritance has been described, and some patients also had coexisting essential tremor (135; 78). Affected first degree relatives were reported in 5% of pedigrees with normal pressure hydrocephalus, and presumed familial normal pressure hydrocephalus has a higher risk of dementia independent of the incidence of Alzheimer disease and ApoE status in these families (49). The copy number loss in the intron 2 of SFMBT1 has been identified as a susceptibility genetic variant in the Japanese population and it was also a predictive factor for a positive response to shunting (102). This was also replicated in Finnish and Norwegian patients as a risk factor for the development of hydrocephalus but not as a positive predictive factor for shunting surgery (65). Another genetic abnormality found in normal pressure hydrocephalus is a heterozygous deletion of the CWH43 gene, which was found in 15% of patients with idiopathic normal pressure hydrocephalus in one studied cohort (132; 115). Cwh43 modifies the lipid anchor of glycosylphosphatidylinositol-anchored proteins, and a mouse model also has hydrocephalus, gait and balance abnormalities, and decreased numbers of ependymal cilia. Additional genes, highly expressed in ependymal cilia, may also play an important role in the pathogenesis of normal pressure hydrocephalus. Mutations affecting nine genes, AK9, RXFP2, PRKD1, HAVCR1, OTOG, MYO7A, NOTCH1, SPG11, and MYH13, are statistically enriched among patients with normal pressure hydrocephalus (131).

The effects of gut microbiota on the development of idiopathic normal pressure hydrocephalus have been also investigated, but more research is needed to further clarify this association (134).

Differential diagnosis

Dementia and gait disorder are the most conspicuous and early signs of normal pressure hydrocephalus. Given the potential for successful treatment, it is imperative to distinguish other conditions simulating the clinical picture of normal pressure hydrocephalus.

Dementing disorders. The most common cause of dementia is Alzheimer disease. Gait in Alzheimer disease is usually unremarkable until the late stages of the illness. Enlarged ventricles can be also found in Alzheimer disease because of brain atrophy (hydrocephalus ex vacuo). The degree of cortical atrophy in hydrocephalus ex vacuo is usually disproportionally more advanced than in patients with normal pressure hydrocephalus. Thus, prominent early gait disorder with relatively short history of dementia in a patient with enlarged ventricles may be more suggestive of normal pressure hydrocephalus than of Alzheimer disease. Patients with coexisting normal pressure hydrocephalus and Alzheimer disease, confirmed by brain biopsy, have diminished postoperative improvement of normal pressure hydrocephalus symptoms (44). The overlap of normal pressure hydrocephalus and Alzheimer disease may be common, and one study found the coexistence of these two entities in 89% (eight of nine cases) (23). Shunting surgery may reduce the risk of the subsequent development of dementia and Alzheimer disease in patients with normal pressure hydrocephalus (118).

Another common type of dementia is dementia with Lewy bodies. This needs to be considered in patients with fluctuating cognitive impairment, visual hallucinations, rapid eye movement (REM) sleep behavior, and mild extrapyramidal features with shuffling gait. Neuroimaging is usually diagnostic in differentiating normal pressure hydrocephalus and dementia with Lewy bodies.

Multi-infarct dementia and Binswanger disease can have similar clinical manifestations, but MRI or CT usually detects signs of multiple strokes. Features seen in multi-infarct dementia not characteristic of normal pressure hydrocephalus include high Hachinski ischemia scale score, presence of multiple infarctions on CT or MRI, focal neurologic deficit, and history of stroke. The presence of associated disease-causing gait changes (osteoarthritis or spinal canal stenosis) may obscure normal pressure hydrocephalus, and these patients should be followed closely for progression and appearance of cognitive deficits. Vascular pathology may be also very common in patients with normal pressure hydrocephalus (69).

Movement disorders. Patients with Parkinson disease also have hypokinetic gaits with a reduced gait velocity and highly variable stride length. Broad-based gait with outward rotated feet and diminished height of the steps can help differentiate normal pressure hydrocephalus from Parkinson disease. Moreover, the gait of patients with normal pressure hydrocephalus does not improve with external cues that are beneficial in patients with Parkinson disease (106). Baseline postural instability of patients with suspected normal pressure hydrocephalus suggests an alternative diagnosis and, if shunted, their outcome tends to be poor (63). Other causes of gait difficulties simulating normal pressure hydrocephalus (eg, spinocerebellar degenerations or cerebellar degeneration due to chronic alcoholism) have more ataxic character (34). Congenital hydrocephalus may become symptomatic with aging and may mimic normal pressure hydrocephalus. Head circumference at or greater than the 98th percentile suggests congenital etiology. Thus, head circumference measurement should be part of an examination in suspected normal pressure hydrocephalus. Furthermore, patients with normal pressure hydrocephalus had bigger head circumference when compared with normal sex-matched and age-matched controls. This suggests that a considerable fraction of these patients actually have a congenital hydrocephalus that became symptomatic in late adulthood (67).

Diagnostic workup

In general, the laboratory evaluation of normal pressure hydrocephalus is difficult. Adhering to a specific protocol for each patient improves the outcomes of diagnostic evaluations of normal pressure hydrocephalus (01). The diagnosis of normal pressure hydrocephalus is supported by the presence of the triad of dementia, gait impairment, and urinary incontinence, together with hydrocephalus seen on CT or MRI with white matter changes, aqueductal CSF flow void sign on MRI, normal pressure of CSF during lumbar puncture, and improvement of clinical symptoms after removal of CSF. Unclear cases may benefit from invasive studies of intracranial pressure monitoring or cerebral compliance. The only premortem definitive confirmation of the diagnosis is improvement after shunt surgery.

Because the clinical picture of normal pressure hydrocephalus is not specific, several diagnostic tests have a crucial role in the diagnosis. The most important diagnostic procedure is CT or MRI scan of the brain to establish the presence of hydrocephalus. The diagnosis of normal pressure hydrocephalus is supported when the width of the anterior ventricular horns is greater than 30% of the cranial cavity (Evans ratio) and inferior horns are wider than 2 mm. These two horns are typically disproportionally enlarged compared to other parts of the ventricular system. However, ventricular dilatation appears to be insufficient for the diagnosis of normal pressure hydrocephalus because the ventricular size does not predict intraventricular pressures (61). Linear measurements of caudocranial alterations of the ventricular geometry such as vertical frontal horn diameters, rather than laterolateral changes of ventricular size, are more sensitive to predict normal pressure hydrocephalus (101). A new index for assessing the total ventricular volume compared to the anteroposterior diameter of the lateral ventricle index has been suggested and the values higher than 0.50 are suggestive of hydrocephalus (47).

Ventriculomegaly and areas of transependymal cerebrospinal fluid leak in normal pressure hydrocephalus (MRI)

T2-weighted MRI demonstrating a ventriculomegaly and areas of transependymal cerebrospinal fluid leak. This patient had complete reversal of his gait disorder, dementia, and urinary incontinence after shunting. (Contributed by Dr....
Hydrocephalus (CT and MRI)

Axial CT (A) and MRI with T2 (B), FLAIR (C), and T1 postcontrast (D) images show prominent ventricles in a patient presenting with the clinical triad of normal pressure hydrocephalus. The FLAIR sequence is sensitive to demonstrati...

Patients with normal pressure hydrocephalus have a unique distribution of CSF with a high ratio between ventricular volume and total intracranial CSF volume; however, the total CSF volume is not different from normal controls (120). The degree of cortical atrophy is usually milder than the degree of ventricular atrophy, but the presence of prominent cortical atrophy does not rule out normal pressure hydrocephalus (130). Disproportional dilatation of the perihippocampal fissure is characteristic for atrophy seen in Alzheimer disease but not in normal pressure hydrocephalus. Voxel-based morphometry of a disproportionate distribution of CSF space between the ventricles and subarachnoid space may help to distinguish normal pressure hydrocephalus from Alzheimer disease or other neurodegenerative processes with global brain atrophy (130). The degree of enlargement of the perihippocampal fissure was a specific and sensitive marker for differentiating normal pressure hydrocephalus (enlarged ventricles and normal or slightly dilated perihippocampal fissure) from hydrocephalus ex vacuo due to Alzheimer disease (enlarged ventricles and perihippocampal fissure) (130). Tight brain convexity with crowding of sulci, resulting in narrowing of subarachnoid spaces in the frontal and parietal lobes, and disproportionate widening of the Sylvian fissure (mismatch sign), which are best assessed on coronal MRI sections, a small callosal angle, and wide temporal horns have been suggested as positive predictors of good shunting outcome (45; 124). Additionally, a small callosal angle, together with the Sylvian fissure dilatation, and absence of narrowing of superior parietal sulci can discriminate the idiopathic normal pressure hydrocephalus from the hydrocephalus ex vacuo (62).

Anatomic features of normal pressure hydrocephalus may be associated with unique mechanical property alterations, and this can be assessed by MR elastography (60). Analysis of 20 different regions of the brain and the summary score of these changes can better predict the surgical outcome of shunted patients than a routine 2D analysis.

Normal size of the fourth ventricle with dilated third and lateral ventricles is suggestive of aqueductal stenosis. This can be corroborated by metrizamide cisternography showing lack of filling above the level of the fourth ventricle. MRI has higher sensitivity to white matter changes than CT, and increased signal in the periventricular area supports the diagnosis of normal pressure hydrocephalus due to transependymal exudation of CSF. However, MRI appearance and the distribution of the white matter changes alone do not have sufficient sensitivity to differentiate normal pressure hydrocephalus from brain pathology due to hypertension (121). Measurement of T1 and T2 water proton relaxation times in the periventricular white matter can distinguish edema in normal pressure hydrocephalus from nonspecific white matter changes (124). Diffusion tensor imaging is more suitable to assess the integrity of white matter, and reduced axonal density of the white matter, representing irreversible changes, is associated with worse prognosis after the shunting (59).

A more specific MRI sign is decreased signal from the aqueduct compared to signal from the ventricles (CSF flow void sign).

Prominent aqueduct flow void in normal-pressure hydrocephalus (MRI)

T2-weighted MRI demonstrating a prominent flow void in the aqueduct, comparable with the degree of flow void in the basilar artery. This patient had an excellent response to shunting. (Contributed by Dr. Peter Hedera.)

Flow velocity in the aqueduct is increased because of reduced compliance of the brain. The presence of CSF flow void sign is not specific for normal pressure hydrocephalus, but its absence may suggest a diagnosis other than normal pressure hydrocephalus (124). Prominent CSF flow void on proton-density weighted images and increased CSF stroke volume have been found in patients with normal pressure hydrocephalus who favorably responded to ventriculoperitoneal shunt (124). However, other studies did not replicate high positive predictive value of CSF flow void or the quantification of the aqueductal stroke volume for shunting outcome (32; 56). Net retrograde aqueductal flow is also a characteristic feature for normal pressure hydrocephalus (100). Overall, MR imaging measurement of intracranial hydrodynamics and brain compliance are abnormal in patients with normal pressure hydrocephalus but cannot reliably predict shunting responders (12).

The Normal Pressure Hydrocephalus Radscale has been proposed as a useful diagnostic tool using radiologic features of normal pressure hydrocephalus. It is a combined scoring of seven different structural imaging markers on preoperative brain CT or MR imaging in patients with idiopathic normal pressure hydrocephalus: callosal angle, Evans Index, Sylvian fissure dilation, apical sulcal narrowing, mean temporal horn diameter, periventricular white matter lesions, and focal sulcal dilation (24). However, a meta-analysis of published radiologic papers found that callosal angle and periventricular changes were the only diagnostically effective radiological predictors of patients with shunt-responsive idiopathic normal pressure hydrocephalus (113).

Drainage of 20 to 50 cc of CSF may transiently improve gait and cognitive abilities, thus, supporting the diagnosis of normal pressure hydrocephalus; however, the test can also give false-negative results (76). A delayed assessment of cognition and mobility 24 hours and especially 48 hours after large volume CSF removal may increase sensitivity to predict a good outcome to shunting (119). Additionally, even a longer post lumbar puncture assessment period was suggested as useful (90). Measurement of cerebral blood flow before and after lumbar puncture can be helpful in preoperative selection of patients. The patients with increased blood flow after a large volume CSF removal have better postoperative prognosis (48; 126). Temporary external lumbar drainage can provide more affirmative information and has a high positive predictive value for improvement after shunt surgery (75). Patients whose clinical picture is highly suggestive of normal pressure hydrocephalus and who did not respond to external continuous lumbar drainage should be further evaluated using more invasive procedures (91). However, some authors have suggested that a high rate of false negative results occur using external lumbar drainage (125). Several centers use invasive measurements of intracranial pressure and CSF infusion tests, which have a high positive predictive value and a relatively low complication rate (95). Cerebral compliance can also be assessed by measuring pressure-volume relationships, which requires intraventricular or lumbar injections with intracranial pressure monitoring. Detection of decreased CSF outflow conductance, which is reciprocal to resistance R(out), has been suggested to be specific for normal pressure hydrocephalus (19). Abnormal cerebral compliance is also useful in differentiation of normal pressure hydrocephalus from cerebral atrophy (82). The Dutch normal pressure hydrocephalus study prospectively assessed the usefulness of measurement of resistance to outflow of CSF in 101 patients. The most reliable results with 92% positive predictive value for good outcome were seen in patients with cut-off levels of 18 mmHg/ml per minute (normal levels are below 10 mmHg/ml per minute) (16). Analysis of 80 patients who were diagnosed during the early stages of normal pressure hydrocephalus and did not have any signs of cognitive deficit did not confirm the usefulness of increased resistance to the outflow of CSF for the prediction of a good outcome after shunting (83); however, other studies replicated a high positive predictive value for a good outcome of abnormal R(out) in patients with normal pressure hydrocephalus (105).

Abnormal circulation and absorption of CSF can be evaluated with radioisotope cisternography. In healthy subjects, intrathecally administered radioisotope accumulates around the brain convexity and is absorbed within 48 hours. Reflux of isotope to the ventricles with ventricular stasis after 48 hours and absence of radioisotope in cisterns has been claimed to be specific for normal pressure hydrocephalus; however, this abnormality seen on cisternography is not specific and has relatively low predictive accuracy (122). Some authors have even completely abandoned this test in the evaluation of normal pressure hydrocephalus (76; 79).

Studies of regional cerebral blood flow and cerebral metabolism in normal pressure hydrocephalus have reported controversial results with nonspecific patterns. Detection of impaired autoregulation with insufficient response to acetazolamide limited to the white matter has been associated with better outcome after surgery (110). PET study has shown globally reduced glucose uptake. This differs from biparietal and bitemporal reduction commonly found in Alzheimer disease (51). Computed tomography perfusion studies can distinguish between healthy controls and patients with hydrocephalus who have reduced perfusion in the white matter and basal ganglia; however, no difference between shunt responders and nonresponders could be demonstrated (136).

Impaired microcirculation and subsequent neuronal dysfunction may be reflected in the composition of cerebrospinal fluid. Total tau protein and hyperphosphorylated tau, beta-amyloid (1-42), vascular endothelial growth factor, glial fibrillary acidic protein, and neurofilament light chain protein have been suggested as potential biomarkers of normal pressure hydrocephalus (33; 112). Meta-analysis of cerebrospinal fluid beta-amyloid (1-42), total tau, and hyperphosphorylated tau levels suggested that these markers are lower in patients with normal pressure hydrocephalus when compared to normal controls (26). Neurofilament light protein and amyloid precursor protein (APP) were reduced in patients with normal pressure hydrocephalus and their levels increased after a successful shunting, possibly reflecting improved axonal integrity (54). However, higher levels of neurofilament light chain and total tau protein were associated with a less favorable response to shunt surgery, suggesting a more active neurodegeneration in this group of patients (21). Increased volume of frontoparietal and periventricular white matter lesions, potentially aggravating the severity of gait disorder, have significantly higher levels of neurofilament light chain (133). Similar results with reduced levels of amyloid precursor protein, total tau, and phosphorylated tau were observed in patients with normal pressure hydrocephalus when compared to patients with Alzheimer disease (86). However, a reduction of the interstitial space in hydrocephalus can impair amyloid precursor protein fragment drainage, resulting in low levels of all forms of amyloid and tau proteins and, thus, provide misleading information to distinguish normal pressure hydrocephalus from Alzheimer disease (40). Assay of Aβ42 toxic conformer may be more sensitive as a biomarker for Alzheimer disease pathology and a subgroup of patients with normal pressure hydrocephalus with increased Aβ42 toxic conformer showed cognitive decline 2 years postoperatively whereas the decreased-conformer subgroup maintained the improvement after the shunting procedure (03).

Management

The only established treatment of normal pressure hydrocephalus is a CSF-diverting operation. American Academy of Neurology practice guidelines state that shunting is possibly effective in idiopathic normal pressure hydrocephalus with a 96% chance of subjective improvement and an 83% chance of improvement on timed walk test at 6 months with three studies with Class 3 evidence (43). Results of a pilot study using a placebo-controlled design with the shunt valve closed in some patients showed a trend for gait improvement in patients who had their valve open for 4 months following surgery (74). Postoperative physical therapy with dynamic equilibrium gait training can facilitate gait recovery and reduce the number of falls (88).

The selection of patients to potentially benefit from a shunt is controversial. It varies from a rigorous approach to offering the benefit of the doubt. An operation should be considered in patients with a history of dementia for less than 2 years and prominent gait impairment; patients with isolated gait impairment are particularly good candidates for an operation (41). Concurrence of cerebrovascular disease predicts poor response to shunt placement (18). Patients who have a high risk of surgical complication may be treated by repeated high-volume lumbar punctures (72).

Marked cortical atrophy is not a contraindication for operation, as many patients with normal pressure hydrocephalus are older. Patients with amelioration of symptoms after lumbar puncture or temporary lumbar drainage are likely to respond positively to a shunt. Invasive monitoring can reduce uncertainty in atypical cases. Resistance to outflow higher than 18 mmHg/ml per minute has the highest positive predictive value for significant improvement (16). Quantitative MRI CSF flow measurement with a CSF stroke volume of more than 42 microliters has also been reported to be useful in predicting outcome of shunting (20).

Indication for the shunt procedure in patients without the typical clinical picture or with a long history of symptoms is difficult. However, patients should be monitored for new symptoms; in particular, demented patients who develop characteristic gait impairment should also be considered for shunt operation (97). There is no conclusive evidence that any type of shunting procedure or valve opening pressure has superior results. However, results of the Dutch normal pressure hydrocephalus study suggest that patients with low-pressure shunts have a tendency for better outcome than patients with medium-pressure valves (17).

Intervention with endoscopic third ventriculostomy for patients with idiopathic normal pressure hydrocephalus has emerged as a potential minimally invasive alternative to traditional treatments (ventriculoperitoneal shunting). The clinical response to these interventions remains variable and unclear (81).

Production of CSF can also be reduced by acetazolamide or digoxin. Patients with high perioperative risk may benefit from a pharmacological approach. Treatment with 125 to 375 mg per day of acetazolamide improved periventricular hyperintensities and gait parameters in a small group of patients with normal pressure hydrocephalus (04).

Outcomes

American Academy of Neurology practice guidelines predictors of successful outcome of shunting included elevated increased resistance to outflow (one study Class 1, multiple Class 2), impaired cerebral blood flow reactivity to acetazolamide (by SPECT) (one study Class 1), and positive response to either external lumbar drainage (one Class 3) or repeated lumbar punctures (43).

Prognosis of patients who have had an operation depends on the selection of cases. The proportion of patients with long-term improvement varies from 25% to 80% and depends on indications for operation, experience of neurosurgeons, and preoperative conditions (123; 96). The clinical benefit from shunting may be sustained for a long-term period (more than 5 years), but these patients still need frequent follow-up visits because shunt complications requiring shunt revisions are relatively common (99). However, shunt-related mortality is negligible (85). Mortality in operated patients with normal pressure hydrocephalus is 1.8 times increased compared to the general population. However, the survival of patients who improve in gait and functional independence are similar to that of the general population, indicating that shunt surgery for idiopathic normal pressure hydrocephalus, besides improving symptoms and signs, can normalize survival (05). Furthermore, early shunt surgery improves the survival and surgery should not be delayed (07). The timing of shunting surgery after the diagnosis is established can also affect the outcomes. Early shunt surgery improves survival, and surgery should not be delayed (07). Patients who underwent a shunting procedure within the first 3 months of the diagnosis had a better outcome than those who delayed surgery (27). Similar results were observed in patients who were considered to have a prodromal stage of idiopathic normal pressure hydrocephalus, and an early intervention in these patients maintained good cognitive and mobility function and social participation ability in the long term (57).

Secondary normal pressure hydrocephalus has a higher rate of beneficial effect from an operation than idiopathic normal pressure hydrocephalus. Prominent gait impairment preceding cognitive impairment or as an isolated symptom is considered to be a good prognostic sign (34). The presence of widespread white matter lesions may reduce the degree of the gait improvement (22).

Best reversibility of dementia has been reported in patients whose verbal memory immediate recall impairment was less than one standard deviation from controls and who had relatively preserved frontal executive and visuospatial functions (114). Another study identified improvement in the Rey Auditory Verbal Learning Test-L after the lumbar CSF drainage as a predictor of cognitive improvement after shunting surgery (80). However, lower ventricular CSF Aβ42 and higher lumbar CSF tau levels did not predict the cognitive outcome after surgery even though these patients had biopsy proven accumulation of Aβ tau proteins (80).

Significant improvement of cognitive function was also seen in patients who had a higher mean value of intracranial pressure before the shunt surgery (36). However, patients who are traditionally considered poor candidates for shunting surgery, such as those with a longer history of dementia, cortical atrophy, and urinary incontinence, may also benefit from shunting and improvement of cognitive status; gait and sphincter incontinence is not uncommon (37; 97). Patients presenting with cognitive decline have a higher risk of developing Alzheimer disease or multiinfarct dementia, and the cognitive outcome of shunting of these patients is relatively poor (64). Definite gait improvement was present in 75% of shunted patients 3 to 6 months after the operation, but it was sustained in only one third of patients at 3 years; the 3-year benefit for cognitive improvement was noted only in one of eight patients, and for urinary continence, in one of six patients (63). Analysis of gait may be also helpful to identify patients with good outcomes and the improvement of speed, stride length, performance-oriented mobility assessment, Berg Balance Scale, and timed up and go times after a high-volume lumbar puncture were associated with good outcome after surgery (38; 92). The wearable sensor system can be used to better analyze gait and quantify specific gait changes that are suggestive for normal pressure hydrocephalus (93; 09). Home-based assessment of gait rather than evaluation in clinical settings can be more sensitive for the detection of gait abnormalities and have better predictive value for shunting outcomes (31).

Decreased ventricular size does not predict a favorable outcome of shunting, and patients with no significant change of the ventricular size tend to have more significant clinical improvement than those with a significant reduction of the ventriculomegaly (84). Three-day external CSF drainage does not noticeably change the ventricular size in spite of observed clinical improvement (70). Patients without clinical improvement and persisting ventriculomegaly in spite of patent shunt and low intracranial pressure are considered to have shunt-nonresponsive hydrocephalus. Dramatic improvement after reduction of the ventricular size by external cerebrospinal fluid drainage with negative pressure (shunt siphoning) has been reported in four patients with shunt-nonresponsive hydrocephalus (13). Volumetric analysis of the caudate, thalamus, putamen, pallidum, hippocampus, and nucleus accumbens demonstrated significant reduction in patients with normal pressure hydrocephalus compared to controls. In the normal pressure hydrocephalus group, smaller caudate and nucleus accumbens volumes were associated with poorer performance on neuropsychological tests and increased severity of neuropsychiatric symptoms whereas reduced volume of the pallidum was associated with better performance on the Mini-Mental State Examination and reduced apathy (94). Analysis of morphometric changes after shunting showed that patients with good response had expansion of brain convexity subarachnoid space (128). Overall, volumetric analysis with fine segmentation could reliably differentiate CSF drainage responders from other normal pressure hydrocephalus-like patients, and it could accurately predict the neurologic outcomes after shunting (127).

Complications of CSF-diverting operations are the main concern. Vanneste and colleagues reviewed results from several hospitals and found the total incidence of complications to reach 30%, but only 5% were serious with long-term sequelae (123). The ratio of substantial benefit to serious harm was approximately three to one, and the strictness of shunt indication did not significantly alter this ratio (123). Subdural hematomas, intracranial infections, stroke, and shunt failure were among the most common complications. Ventriculoatrial shunts may cause cardiac tamponade or pulmonary embolism, and ventriculoperitoneal shunt may cause ascites or injury to abdominal organs. Prophylactic therapy with aspirin increases the risk of subdural hematoma (14).

The majority of untreated cases, or those with a failed shunt, progress with deterioration of dementia, development of akinetic state, and urine and stool incontinence (117). Progression can be fast, and the follow-up of surgical candidates for shunting showed a significant progression even within a 3-month period, further supporting a timely surgery when indicated (06). Patients are at risk for fractures and other injuries, including subdural hematoma, from falls. Immobilization can be complicated by pneumonia, pulmonary embolism, decubiti, urinary tract infections, and sepsis.

Media

References

01: Acosta LMY, Stubblefield K, Conwell T, et al. Protocolizing the work-up for idiopathic normal pressure hydrocephalus improves outcomes. Neurol Clin Prac 2021;11(4):e447-53. PMID 34484943
02: Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with 'normal' cerebrospinal fluid pressure: a treatable syndrome. N Engl J Med 1965;273:117-26. PMID 14303656
03: Akiba C, Nakajima M, Miyajima M, et al. Change of amyloid-β 1-42 toxic conformer ratio after cerebrospinal fluid diversion predicts long-term cognitive outcome in patients with idiopathic normal pressure hydrocephalus. J Alzheimers Dis 2018;63(3):989-1002. PMID 29710721
04: Alperin N, Oliu CJ, Bagci AM, et al. Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH. Neurology 2014;82(15):1347-51. PMID 24634454
05: Andren K, Wikkelsø C, Sundström N, et al. Survival in treated idiopathic normal pressure hydrocephalus. J Neurol 2020;267(3):640-8. PMID 31713102
06: Andren K, Wikkelso, Tisell M, Hellstrom P. Natural course of idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2014;85(7):806-10. PMID 24292998
07: Andren K, Wikkelso, Tisell M, Hellstrom P, Tullberg M, Jaraj D. Early shunt surgery improves survival in idiopathic normal pressure hydrocephalus. Eur J Neurol 2021;28(4):1153-9. PMID 33316127
08: Artru AA. Effects of halothane and fentanyl anesthesia on resistance to reabsorption of CSF. J Neurosurg 1984;60:252-6. PMID 6693952
09: Atbas E, Gaydecki P, Callaghan M. A wearable gait-analysis device for idiopathic normal-pressure hydrocephalus (INPH) monitoring. Biomed Phys Eng Express 2024. [Epub ahead of print] PMID 38364278
10: Bae YJ, Choi BS, Kim JM, et al. Altered glymphatic system in idiopathic normal pressure hydrocephalus. Parkinsonism Relat Disord 2021;82:56-60. PMID 33248394
11: Bateman GA. The pathophysiology of idiopathic normal pressure hydrocephalus: cerebral ischemia or altered venous hemodynamics. AJNR Am J Neuroradiol 2008;29(1):198-203. PMID 17925373
12: Bateman GA, Loiselle AM. Can MR measurement of intracranial hydrodynamics and compliance differentiate which patient with idiopathic normal pressure hydrocephalus will improve following shunt insertion. Acta Neurochir (Wien) 2007;149(5):455-62. PMID 17406777
13: Bergsneider M, Peacock WJ, Mazziotta JC, Becker DP. Beneficial effect of siphoning in treatment of adult hydrocephalus. Arch Neurol 1999;56:1224-9. PMID 10520938
14: Birkeland P, Lauritsen J, Poulsen FR. Aspirin is associated with an increased risk of subdural hematoma in normal-pressure hydrocephalus patients following shunt implantation. J Neurosurg 2015;123(2):423-6. PMID 25555087
15: Bluett B, Ash E, Farheen A, et al. Clinical features of idiopathic normal pressure hydrocephalus: critical review of objective findings. Mov Disord Clin Pract 2022;10(1):9-16. PMID 36704075
16: Boon AJ, Tans JT, Delwel EJ, et al. Dutch normal-pressure hydrocephalus study: prediction of outcome after shunting by resistance to outflow of cerebrospinal fluid. J Neurosurg 1997;87(5):687-93. PMID 9347976
17: Boon AJ, Tans JT, Delwel EJ, et al. Dutch normal-pressure hydrocephalus study: randomized comparison of low- and medium-pressure shunts. J Neurosurg 1998;88(3):490-5. PMID 9488303
18: Boon AJ, Tans JT, Delwel EJ, et al. Dutch normal-pressure hydrocephalus study: the role of cerebrovascular disease. J Neurosurg 1999;90(2):221-6. PMID 9950492
19: Borgesen SE, Gjerris F. Relationships between intracranial pressure, ventricular size, and resistance to CSF outflow. J Neurosurg 1987;67(4):535-9. PMID 3655891
20: Bradley WG, Scalzo D, Queralt J, Nitz WN, Atkinson DJ, Wong P. Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MRI imaging. Radiology 1996;198:523-9. PMID 8596861
21: Braun M, Bjurnemark C, Seo W, et al. Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus. Fluids Barriers CNS 2022;19(1):15. PMID 35164790
22: Bugalho P, Alves L. Normal-pressure hydrocephalus: white matter lesions correlate negatively with gait improvement after lumbar puncture. Clin Neurol Neurosurg 2007;109(9):774-8. PMID 17768003
23: Cabral D, Beach TG, Vedders L, et al. Frequency of Alzheimer’s disease pathology at autopsy in patients with clinical normal pressure hydrocephalus. Alzheimers Dement 2011;7(5):509-13. PMID 21723206
24: Carlsen JF, Backlund ADL, Mardal CA, et al. Can shunt response in patients with idiopathic normal pressure hydrocephalus be predicted from preoperative brain imaging? A retrospective study of the diagnostic use of the Normal Pressure Hydrocephalus Radscale in 119 patients. AJNR Am J Neuroradiol 2022;43(2):223-9. PMID 34969666
25: Chang CC, Asada H, Mimura T, Suzuki S. A prospective study of cerebral blood flow and cerebrovascular reactivity to acetazolamide in 162 patients with idiopathic normal-pressure hydrocephalus. J Neurosurg 2009;111(3):610-7. PMID 19284245
26: Chen Z, Liu C, Zhang J, Relkin N, Xing Y, Li Y. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis. Fluids Barriers CNS 2017;14(1):13. PMID 28486988
27: Chidiac C, Sundström N, Tullberg M, Arvidsson L, Olivecrona M. Waiting time for surgery influences the outcome in idiopathic normal pressure hydrocephalus - a population-based study. Acta Neurochir (Wien) 2022;164(2):469-78. PMID 34970701
28: Chistyakov AV, Hafner H, Sinai A, Kaplan B, Zaaroor M. Motor cortex disinhibtion in normal-pressure hydrocephalus. J Neurosurg 2012;116(2):453-9. PMID 21999318
29: Constantinescu C, Wikkelsø C, Westman E, et al. Prevalence of possible idiopathic normal pressure hydrocephalus in Sweden: a population-based MRI study in 791 70-year-old participants. Neurology 2024;102(2):e208037. PMID 38165321
30: Deng Z, Wang H, Huang K, et al. Association between vascular risk factors and idiopathic normal pressure hydrocephalus: a Mendelian randomization study. J Neurol 2023. PMID 36773060
31: Dias SF, Graf C, Jehli E, et al. Gait pattern analysis in the home environment as a key factor for the reliable assessment of shunt responsiveness in patients with idiopathic normal pressure hydrocephalus. Front Neurol 2023;4:1126298. PMID 37082443
32: Dixon GR, Friedman JA, Luetmer PH, et al. Use of cerebrospinal fluid flow rates measured by phase-contrast MR to predict outcome of ventriculoperitoneal shunting for idiopathic normal-pressure hydrocephalus. Mayo Clin Proc 2002;77(6):509-14. PMID 12059119
33: Eide PK, Stanisic M. Cerebral microdialysis and intracranial pressure monitoring in patients with idiopathic normal-pressure hydrocephalus: association with clinical response to extended lumbar drainage and shunt surgery. J Neurosurg 2010;112(2):414-24. PMID 19538048
34: Fisher CM. Hydrocephalus as a cause of disturbances of gait in the elderly. Neurology 1982;32:1358-63. PMID 6890641
35: Foltz EL, Aine C. Diagnosis of hydrocephalus by CSF pulse analysis: a clinical study. Surg Neurol 1980;15:283-93. PMID 7245015
36: Foss T, Eide PK, Finset A. Intracranial pressure parameters in idiopathic normal pressure hydrocephalus patients with and without improvement of cognitive function after shunt treatment. Dement Geriatr Cogn Disord 2006;23:47-54. PMID 17077633
37: Friedland RP. ‘Normal’-pressure hydrocephalus and the saga of the treatable dementias. JAMA 1989;262(18):2577-81. PMID 2535659
38: Gallagher R, Marquez J, Osmotherly P. Gait and balance measures can identify change from a cerebrospinal fluid tap test in idiopathic normal pressure hydrocephalus. Arch Phys Med Rehabil 2018;99(11):2244-50. PMID 29702069
39: Georgiopoulos C, Tisell A, Holmgren RT, et al. Noninvasive assessment of glymphatic dysfunction in idiopathic normal pressure hydrocephalus with diffusion tensor imaging. J Neurosurg 2023;140(3):612-20. PMID 37724800
40: Graff-Radford NR. Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology 2014;83(17):1573-5. PMID 25332445
41: Graff-Radford NR, Godersky JC. Normal-pressure hydrocephalus. Onset of gait abnormality before dementia predicts good surgical outcome. Arch Neurol 1986;43:940-2. PMID 3741212
42: Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965;2:307-27. PMID 5889177
43: Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss D. Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2015;85(23):2063-71.** PMID 26644048
44: Hamilton R, Patel S, Lee EB, et al. Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 2010;68(4):535-40. PMID 20687117
45: Hashimoto M, Ishikawa M, Mori E, Kuwana N; The study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 2010;7(1):18. PMID 21040519
46: Hattori T, Yuasa T, Aoki S, et al. Altered microstructure in corticospinal tract in idiopathic normal pressure hydrocephalus: comparison with Alzheimer disease and Parkinson disease with dementia. AJNR Am J Neuroradiol 2011;32(9):1681-7. PMID 21816921
47: He W, Fang X, Wang X, et al. A new index for assessing cerebral ventricular volume in idiopathic normal-pressure hydrocephalus: a comparison with Evans' index. Neuroradiology 2020;62(6):661-7. PMID 32008047
48: Hertel F, Walter C, Schmitt M, et al. Is a combination of Tc-SPECT or perfusion weighted magnetic resonance imaging with spinal test helpful in the diagnosis of normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2003;74(4):479-84. PMID 12640067
49: Huovinen J, Kastinen S, Komulainen S, et al. Familial idiopathic normal pressure hydrocephalus. J Neurol Sci 2016;368:11-8. PMID 27538594
50: Iseki C, Takahashi Y, Adachi M, et al. Prevalence and development of idiopathic normal pressure hydrocephalus: a 16-year longitudinal study in Japan. Acta Neurol Scand 2022;146(5):680-9. PMID 36114711
51: Jagust WJ, Friedland RP, Budinger TF. Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiatry 1985;48(11):1091-6. PMID 3878390
52: Jaraj D, Agerskov S, Rabiei K, et al. Vascular factors in suspected normal pressure hydrocephalus: a population-based study. Neurology 2016;86(7):592-9.** PMID 26773072
53: Jaraj D, Rabiei K, Marlow T, Jensen C, Skoog I, Wikkelsø C. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology 2014;82:1149-1454. PMID 24682964
54: Jeppsson A, Zetterberg H, Blennow K, Wikkelso C. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. Neurology 2013;80(15):1385-92. PMID 23486875
55: Jurcoane A, Keil F, Szelenyi A, Pfeilschifter W, Singer OC, Hattingen E. Directional diffusion of corticospinal tract supports therapy decisions in idiopathic normal-pressure hydrocephalus. Neuroradiology 2014;56(1):5-13. PMID 24158631
56: Kahlon B, Annertz M, Stahlberg F, Rehncrona S. Is aqueductal stroke volume, measured with cine phase-contrast magnetic resonance imaging scans useful in predicting outcome of shunt surgery in suspected normal pressure hydrocephalus. Neurosurgery 2007;60(1):124-9. PMID 17228260
57: Kajimoto Y, Kameda M, Kambara A, et al. Impact of early intervention for idiopathic normal pressure hydrocephalus on long-term prognosis in prodromal phase. Front Neurol 2022;13:866352. PMID 35481276
58: Kamiya K, Hori M, Irie R, et al. Diffusion imaging of reversible and irreversible microstructural changes within the corticospinal tract in idiopathic normal pressure hydrocephalus. Neuroimage Clin 2017;14:663-71. PMID 28348958
59: Kang K, Yoon U, Choi W, Lee HW. Diffusion tensor imaging of idiopathic normal-pressure hydrocephalus and the cerebrospinal fluid tap test. J Neurol Sci 2016;364(5):90-6. PMID 27084223
60: Karki P, Murphy MC, Cogswell PC, el. Prediction of surgical outcomes in normal pressure hydrocephalus by MR elastography. AJNR Am J Neuroradiol 2024;45(3):328-34. PMID 38272572
61: Kim E, Lim YJ, Park HS, et al. The lack of relationship between intracranial pressure and cerebral ventricle indices based on brain computed tomography in patients undergoing ventriculoperitoneal shunt. Acta Neurochir (Wien) 2015;157(2):257-63. PMID 25503296
62: Kim M, Park SW, Lee JY, et al. Differences in brain morphology between hydrocephalus ex vacuo and idiopathic normal pressure hydrocephalus. Psychiatry Investig 2021;18(7):628-35. PMID 34265199
63: Klassen BT, Ahlskog JE. Normal pressure hydrocephalus: how often does the diagnosis hold water. Neurology 2011;77(12):1119-25. PMID 21849644
64: Koivisto AM, Alafuzoff I, Savolainen S, et al. Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus. Neurosurgery 2013;72(1):1-8. PMID 23037817
65: Korhonen VE, Helisalmi S, Jokinen A, et al. Copy number loss in SFMBT1 is common among Finnish and Norwegian patients with iNPH. Neurology Genet 2018;4(6):e291. PMID 30584596
66: Kosteljanetz M. CSF dynamics and pressure-volume relationships in communicating hydrocephalus. J Neurosurg 1986;64:45-52. PMID 3941350
67: Krefft TA, Graff-Radford NR, Lucas JA, Mortimer JA. Normal pressure hydrocephalus and large head size. Alzheimer Dis Assoc Disord 2004;18(1):35-7. PMID 15195461
68: Kuriyama N, Tokuda T, Miyamoto J, Takayasu N, Kondo M, Nakagawa M. Retrograde jugular flow associated with idiopathic normal pressure hydrocephalus. Ann Neurol 2008;64(2):217-21. PMID 18570299
69: Leinonen V, Koivisto AM, Savolainen S, et al. Post-mortem findings in 10 patients with presumed normal pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 2012;38(1):72-86. PMID 21696417
70: Lenfeldt N, Hansson W, Larsson A, Birgander R, Eklund A, Malm J. Three-day CSF drainage barely reduces ventricular size in normal pressure hydrocephalus. Neurology 2012;79(3):237-42. PMID 22764254
71: Lenfeldt N, Larsson A, Nyberg L, et al. Idiopathic normal pressure hydrocephalus: increased supplementary motor activity accounts for improvement after CSF drainage. Brain 2008;131(Pt 11):2904-12. PMID 18931387
72: Lim TS, Yong SW, Moon SY. Repetitive lumbar punctures as treatment for normal pressure hydrocephalus. Eur Neurol 2009;62(5):293-7. PMID 19713705
73: Lim YH, Ko PW, Park KS, et al. Quantitative gait analysis and cerebrospinal fluid tap test for idiopathic normal-pressure hydrocephalus. Sci Rep 2019;9(1):16255. PMID 31700018
74: Luciano M, Holubkov R, Williams MA, et al. Placebo-controlled effectiveness of idiopathic normal pressure hydrocephalus shunting: a randomized pilot trial. Neurosurgery 2023;92(3):481-9. PMID 36700738
75: Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 2005a;57(Suppl):S2-17. PMID 16160426
76: Marmarou A, Young HF, Aygok GA, et al. Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study of 151 patients. J Neurosurg 2005b;102:987-97. PMID 16028756
77: Martín-Láez R, Caballero-Arzapalo H, López-Menéndez LÁ, Arango-Lasprilla JC, Vázquez-Barquero A. Epidemiology of idiopathic normal pressure hydrocephalus: a systematic review of the literature. World Neurosurg 2015;84(6):2002-9. PMID 26183137
78: McGirr A, Cusimano MD. Familial aggregation of idiopathic normal pressure hydrocephalus: novel familial case and a family study of the NPH triad in an iNPH patient cohort. J Neurol Sci 2012;321(1-2):82-8. PMID 22921954
79: McGirt MJ, Woodworth G, Coon AL, et al. Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:699-705. PMID 16239882
80: McGovern RA, Nelp TB, Kelly KM, et al. Predicting cognitive improvement in normal pressure hydrocephalus patients using preoperative neuropsychological testing and cerebrospinal fluid biomarkers. Neurosurgery 2019;85(4):E662-9. PMID 30937451
81: Mehta NH, Greenberg ABW, Kahle KT. The efficacy of endoscopic third ventriculostomy for idiopathic normal pressure hydrocephalus. World Neurosurg 2023;179(11):158-66. PMID 37625638
82: Meier U, Bartels P. The importance of the intrathecal infusion test in the diagnosis of normal pressure hydrocephalus. J Clin Neurosci 2002;9:260-7. PMID 12093131
83: Meier U, Miethke C. Predictors of outcome in patients with normal-pressure hydrocephalus. J Clin Neurosci 2003;10(4):453-9. PMID 12852885
84: Meier U, Mutze S. Correlation between decreased ventricular size and positive clinical outcome following shunt placement in patients with normal-pressure hydrocephalus. J Neurosurg 2004;100(6):1036-40. PMID 15200118
85: Mirzayan MJ, Luetjens G, Borremans JJ, Regel JP, Krauss JK. Extended long-term (> 5 years) outcome of cerebrospinal fluid shunting in idiopathic normal pressure hydrocephalus. Neurosurgery 2010;67(2):295-301. PMID 20644414
86: Miyajima M, Nakajima M, Ogino I, Miyata H, Motoi Y, Arai H. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol 2013;20(2):236-42. PMID 22672777
87: Momjian S, Owler BK, Czosnyka Z, Czosnyka M, Pena A, Pickard JD. Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 2004;127(Pt 5):965-72. PMID 15033897
88: Nikaido Y, Urakami H, Okada Y, et al. Rehabilitation effects in idiopathic normal pressure hydrocephalus: a randomized controlled trial. J Neurol 2023;270(1):357-68. PMID 36071284
89: Nowak DA, Gumprecht H, Topka H. CSF drainage ameliorates the motor deficit in normal pressure hydrocephalus: evidence from the analysis of grasping movements. J Neurol 2006;253:640-7. PMID 16767541
90: Oike R, Inoue Y, Ota Y, Sorimachi T. The necessity of gait evaluation on the 7th day after tap tests for the idiopathic normal pressure hydrocephalus patients. BMC Geriatr 2023;23(1):776. PMID 38012563
91: Panayiotopoulos V, Konstantinou D, Kalogeropoulos A, Maraziotis T. The predictive value of external continuous lumbar drainage, with cerebrospinal fluid outflow controlled by medium pressure valve, in normal pressure hydrocephalus. Acta Neurochir 2005;147:953-8. PMID 16041469
92: Panciani PP, Migliorati K, Muratori A, Gelmini M, Padovani A, Fontanella M. Computerized gait analysis with inertial sensor in the management of idiopathic normal pressure hydrocephalus. Eur J Phys Rehabil Med 2018;54(5):724-9. PMID 29962192
93: Passaretti M, Maranzano A, Bluett B, Rajalingam R, Fasano A. Gait analysis in idiopathic normal pressure hydrocephalus: a meta-analysis. Mov Disord Clin Pract 2023;10(11):1574-84. PMID 38026510
94: Peterson KA, Mole TB, Keong NCH, et al. Structural correlates of cognitive impairment in normal pressure hydrocephalus. Acta Neurol Scand 2019;139(3):305-12. PMID 30428124
95: Pfisterer WK, Aboul-Enein F, Gebhart E, Graf M, Aichholzer M, Muhlbauer M. Continuous intraventricular pressure monitoring for diagnosis of normal-pressure hydrocephalus. Acta Neurochir (Wien) 2007;149(10):983-90. PMID 17676411
96: Poca MA, Mataro M, Del Mar Matarin M, Arikan F, Junque C, Sahuquillo J. Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk. Results of study based on continuous monitoring of intracranial pressure. J Neurosurg 2004;100(5):855-66. PMID 15137605
97: Poca MA, Mataro M, Matarin M, Arikan F, Junque C, Sahuquillo J. Good outcome in patients with normal-pressure hydrocephalus and factors indicating poor prognosis. J Neurosurg 2005;103:455-63. PMID 16235677
98: Pozzi NG, Brumberg J, Todisco M, et al. Striatal dopamine deficit and motor impairment in idiopathic normal pressure hydrocephalus. Mov Disord 2021;36(1):124-32. PMID 33151012
99: Pujari S, Kharkar S, Metellus P, Shuck J, Williams MA, Rigamonti D. Normal pressure hydrocephalus: long term outcome after shunt surgery. J Neurol Neurosurg Psychiatry 2008:79(11):1286-6. PMID 18356257
100: Ringstad G, Emblem KE, Eide PK. Phase-contrast magnetic resonance imaging reveals net retrograde aqueductal flow in idiopathic normal pressure hydrocephalus. J Neurosurg 2016;124(6):1850-7. PMID 26636385
101: Ryska P, Slezak O, Eklund A, Malm J, Salzer J, Zizka J. Radiological markers of idiopathic normal pressure hydrocephalus: relative comparison of their diagnostic performance. J Neurol Sci 2020;408:116581. PMID 31760225
102: Sato H, Takahashi Y, Kimihira L, et al. A segmental copy number loss of the SFMBT1 gene is a genetic risk for shunt-responsive, idiopathic normal pressure hydrocephalus (iNPH): a case-control study. PLoS One 2016;11(11):e0166615. PMID 27861535
103: Silveberg GD, Huhn S, Jaffe RA, et al. Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. J Neurosurg 2002;97:1271-5. PMID 12507122
104: Singer OC, Melber J, Hattingen E, et al. MR volumetric changes after diagnostic CSF removal in normal pressure hydrocephalus. J Neurol 2012;259(11):2440-6. PMID 22592285
105: Sorterberg A, Eide PK, Fremming AD. A prospective study on the clinical effect of surgical treatment of normal-pressure hydrocephalus: the value of hydrodynamic evaluation. Br J Neurosurg 2004;18:149-57. PMID 15176556
106: Stolze H, Kuhtz-Buschbeck JP, Drucke H, Johnk K, Illert M, Deutschl G. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson’s disease. J Neurol Neurosurg Psychiatry 2001;70:289-97. PMID 11181848
107: Switzer AR, Graff-Radford J, Gunter JL, et al. Patients with normal pressure hydrocephalus have fewer enlarged perivascular spaces in the centrum semiovale compared to cognitively unimpaired individuals. Clin Neurol Neurosurg 2024;237(2):108123. PMID 38262154
108: Takahashi Y, Kawanami T, Nagasawa H, Iseki C, Hanyu H, Kato T. Familial normal pressure hydrocephalus (NPH) with an autosomal-dominant inheritance: a novel subgroup of NPH. J Neurol Sci 2011;308(1-2):149-51. PMID 21704338
109: Tan C, Wang X, Wang Y, et al. Altered glymphatic system in idiopathic normal pressure hydrocephalus. Clin Interv Aging 2021;16:139-53. PMID 33488070
110: Tanaka A, Kimura M, Nakayama Y, Yoshinaga S, Tomonaga M. Cerebral blood flow and autoregulation in normal pressure hydrocephalus. Neurosurgery 1997;40:1161-7. PMID 9179888
111: Tang YM, Yao Y, Xu S, et al. White matter microstructural damage associated with gait abnormalities in idiopathic normal pressure hydrocephalus. Front Aging Neurosci 2021;13:660621. PMID 34434100
112: Tarnaris A, Toma AK, Chapman MD, Keir G, Kitchen ND, Watkins LD. Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurosurg 2011;115(1):145-50. PMID 21438653
113: Thavarajasingam SG, El-Khatib M, Vemulapalli K, et al. Radiological predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir (Wien) 2023;165(2):369-419. PMID 36435931
114: Thomas G, McGirt MJ, Woodworth GF, et al. Baseline neuropsychological profile and cognitive response to cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus. Dement Geriatr Cogn Disord 2005;20:163-8. PMID 16020945
115: Tipton PW, Atik M, Soto-Beasley AI, et al. CWH43 variants are associated with disease risk and clinical phenotypic measures in patients with normal pressure hydrocephalus. Neurol Genet 2023;9(5):e200086. PMID 37476022
116: Todisco M, Zangaglia R, Minifra B, et al. Clinical outcome and striatal dopaminergic function after shunt surgery in patients with idiopathic normal pressure hydrocephalus. Neurology 2021;96(23):e2861-73. PMID 33893195
117: Toma AK, Stapleton S, Papadopoulos MC, Kitchen ND, Watkins LD. Natural history of idiopathic normal-pressure hydrocephalus. Neurosurg Rev 2011;34(4):433-9. PMID 21594683
118: Tseng PH, Huang WT, Wang JH, Huang BR, Huang HY, Tsai ST. Cerebrospinal fluid shunt surgery reduces the risk of developing dementia and Alzheimer's disease in patients with idiopathic normal pressure hydrocephalus: a nationwide population-based propensity-weighted cohort study. Fluids Barriers CNS 2024;21(1):16. PMID 38355601
119: Tsimiklis C, Mascarenhas A, To MS, et al. The benefit of delayed reassessment post high-volume CSF removal in the diagnosis of shunt-responsive idiopathic normal-pressure hydrocephalus. J Clin Neurosci 2020;71:32-8. PMID 31843431
120: Tsunoda A, Mitsuoka H, Bandai H, Arai H, Sato K, Makita J. Intracranial cerebrospinal fluid distribution and its postoperative changes in normal pressure hydrocephalus. Acta Neurochir 2001;143:493-9. PMID 11482700
121: Tullberg M, Hultin L, Ekholm S, Mansson JE, Fredman P, Wikkelso C. White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol Scand 2002;105:417-26. PMID 12027829
122: Vanneste J, Augustijn P, Davies GA, Dirven C, Tan WF. Normal pressure hydrocephalus. Is cisternography still useful in selecting patients for a shunt. Arch Neurol 1992a;49:366-70. PMID 1558516
123: Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD. Shunting normal-pressure hydrocephalus: do the benefits outweigh the risk. A multicenter study and literature review. Neurology 1992b;42:54-9. PMID 1734324
124: Virhammar J, Laurell K, Cesarini KG, Larsson EM. Preoperative prognostic value of MRI findings in 108 patients with idiopathic normal pressure Hydrocephalus. AJNR Am J Neuroradiol 2014;35(12):2311-8. PMID 25012669
125: Walchenbach R, Geiger E, Thomeer R, Vanneste J. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2002;72(4):503-6. PMID 11909911
126: Walter C, Hertel F, Naumann E, Morsdorf M. Alteration of cerebral perfusion in patients with idiopathic normal pressure hydrocephalus measured by 3D perfusion weighted magnetic resonance imaging. J Neurol 2005;252:1465-71. PMID 16021357
127: Wu D, Moghekar A, Shi W, Blitz AM, Mori S. Systematic volumetric analysis predicts response to CSF drainage and outcome to shunt surgery in idiopathic normal pressure hydrocephalus. Eur Radiol 2021;31(7):4972-80. PMID 33389035
128: Yamada S, Ishikawa M, Yamaguchi M, Yamamoto K. Longitudinal morphological changes during recovery from brain deformation due to idiopathic normal pressure hydrocephalus after ventriculoperitoneal shunt surgery. Sci Rep 2019;9(1):17318. PMID 31754171
129: Yamada S, Ishikawa M, Yamamoto K, et al. Aneurysm location and clipping versus coiling for development of secondary normal-pressure hydrocephalus after aneurysmal subarachnoid hemorrhage: Japanese Stroke DataBank. J Neurosurg 2015;123(6):1555-61. PMID 26230474
130: Yamashita F, Sasaki M, Saito M, et al. Voxel-based morphometry of disproportionate cerebrospinal fluid space distribution for the differential diagnosis of idiopathic normal pressure hydrocephalus. J Neuroimaging 2014;24(4):359-65. PMID 24033752
131: Yang HW, Lee S, Berry BC, et al. A role for mutations in AK9 and other genes affecting ependymal cells in idiopathic normal pressure hydrocephalus. Proc Natl Acad Sci U S A 2023a;120(51):e2300681120. PMID 38100419
132: Yang HW, Lee S, Yang D, et al. Deletions in CWH43 cause idiopathic normal pressure hydrocephalus. EMBO Mol Med 2021;13(3):e13249. PMID 33459505
133: Yang L, Yang F, Deng Y, Yan A, Wei W, Fang X. White matter hyperintensity mediating gait disorders in iNPH patients via neurofilament light chain. Front Aging Neurosci 2023b;15:1117675. PMID 37032824
134: Zhang H, Mao W, Zhang Y. The causal effect of gut microbiota on the development of idiopathic normal pressure hydrocephalus. World Neurosurg 2024;181:e983-9. PMID 37952884
135: Zhang J, Carr CW, Rigamonti D, Badr A. Genome-wide linkage scan maps ETINPH gene to chromosome 19q12-13.31. Hum Hered 2010;69(4):262-7. PMID 20357477
136: Ziegelitz D, Arvidsson J, Hellström P, Tullberg M, Wikkelsø C, Starck G. In patients with idiopathic normal pressure hydrocephalus postoperative cerebral perfusion changes measured by dynamic susceptibility contrast magnetic resonance imaging correlate with clinical improvement. J Comput Assist Tomogr 2015;39(4):531-40. PMID 25974719

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Peter Hedera MD PhD

Dr. Hedera of the University of Louisville has no relevant financial relationships to disclose.
See Profile
Robert P Friedland MD

Dr. Friedland of the University of Louisville School of Medicine has no relevant financial relationships to disclose.
See Profile

Editor

Howard S Kirshner MD

Dr. Kirshner of Vanderbilt University School of Medicine has no relevant financial relationships to disclose.
See Profile

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: male=female
Heredity: Autosomal dominant in unknown proportion of cases
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-11: Normal-pressure hydrocephalus: 8D64.04
OMIM: Hydrocephalus, normal-pressure, 1; HYDNP1: 236690

Tremor, hereditary essential, and idiopathic normal pressure hydrocephalus; ETINPH: 611808

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Normal pressure hydrocephalus

Associated Disorders

Carcinomatous meningitis (Leptomeningeal metastasis)
Chronic meningitis
Elevated CSF protein level
Essential tremor
Subarachnoid hemorrhage

Differential Diagnosis

Alzheimer disease
Binswanger disease
Dementia with Lewy bodies
Multi-infarct dementia
Parkinson disease
- Subcortical vascular cognitive impairment
- Vascular cognitive impairment

Also Relevant

Gait disorders
Hydrocephalus
Memory loss
Mental status examination
Neurodegenerative disorders: treatment with neurotrophic factors
- Neurologic disorders associated with behavioral symptoms
- Neurologic disorders of aging
- Neurosurgical shunts and their complications
- Subcortical vascular cognitive impairment
- Urinary dysfunction in neurologic disorders
- Vascular cognitive impairment

Normal pressure hydrocephalus (NPH) …

Normal pressure hydrocephalus

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Authors

Editor

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Metal neurotoxicity

Vascular cognitive impairment

Addictive disorders

Automatic-voluntary dissociation

Wilson disease

Pre-mild cognitive impairment

PART (Primary age-related tauopathy)

Anti-LGI1 encephalitis

Normal pressure hydrocephalus

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Authors

Editor

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Metal neurotoxicity

Vascular cognitive impairment

Addictive disorders

Automatic-voluntary dissociation

Wilson disease

Pre-mild cognitive impairment

PART (Primary age-related tauopathy)

Anti-LGI1 encephalitis

This is an article preview.
Start a Free Account
to access the full version.